BR112019008606A2 - inibidores de interações de mtor-deptor e métodos de uso dos mesmos - Google Patents

inibidores de interações de mtor-deptor e métodos de uso dos mesmos

Info

Publication number
BR112019008606A2
BR112019008606A2 BR112019008606A BR112019008606A BR112019008606A2 BR 112019008606 A2 BR112019008606 A2 BR 112019008606A2 BR 112019008606 A BR112019008606 A BR 112019008606A BR 112019008606 A BR112019008606 A BR 112019008606A BR 112019008606 A2 BR112019008606 A2 BR 112019008606A2
Authority
BR
Brazil
Prior art keywords
deptor
inhibitors
mtor
interactions
methods
Prior art date
Application number
BR112019008606A
Other languages
English (en)
Inventor
Lichtenstein Alan
Lee Jihye
F Gera Joseph
E Jung Michael
Shi Yijiang
Original Assignee
Univ California
The Us Gov Represented By The Department Of Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California, The Us Gov Represented By The Department Of Veterans Affairs filed Critical Univ California
Publication of BR112019008606A2 publication Critical patent/BR112019008606A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • C07C251/84—Hydrazones having doubly-bound carbon atoms of hydrazone groups being part of rings other than six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/15—Oximes (>C=N—O—); Hydrazines (>N—N<); Hydrazones (>N—N=) ; Imines (C—N=C)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/02—Compounds containing any of the groups, e.g. carbazates
    • C07C281/04—Compounds containing any of the groups, e.g. carbazates the other nitrogen atom being further doubly-bound to a carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/10—Systems containing only non-condensed rings with a five-membered ring the ring being unsaturated

Abstract

são aqui proporcionados compostos de hidrazona substituídos, úteis como inibidores de deptor. a invenção proporciona ainda composições farmacêuticas dos compostos da invenção. a invenção também proporciona usos médicos de compostos hidrazona substituídos.
BR112019008606A 2016-11-07 2017-11-06 inibidores de interações de mtor-deptor e métodos de uso dos mesmos BR112019008606A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662418362P 2016-11-07 2016-11-07
PCT/US2017/060116 WO2018085753A1 (en) 2016-11-07 2017-11-06 Inhibitors of mtor-deptor interactions and methods of use thereof

Publications (1)

Publication Number Publication Date
BR112019008606A2 true BR112019008606A2 (pt) 2019-07-09

Family

ID=62076420

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112019008606A BR112019008606A2 (pt) 2016-11-07 2017-11-06 inibidores de interações de mtor-deptor e métodos de uso dos mesmos

Country Status (13)

Country Link
US (1) US20190330142A1 (pt)
EP (1) EP3535239A1 (pt)
JP (1) JP2019535815A (pt)
KR (1) KR20190114955A (pt)
CN (1) CN109952287A (pt)
AU (1) AU2017355566A1 (pt)
BR (1) BR112019008606A2 (pt)
CA (1) CA3039070A1 (pt)
IL (1) IL266344A (pt)
MX (1) MX2019005294A (pt)
RU (1) RU2019112671A (pt)
SG (1) SG11201902465TA (pt)
WO (1) WO2018085753A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102114899B1 (ko) * 2020-02-26 2020-05-26 가천대학교 산학협력단 mSIN1 단백질 억제제를 유효성분으로 함유하는 불임 또는 유산의 예방 또는 치료용 약학적 조성물
KR102147491B1 (ko) * 2020-05-29 2020-08-25 가천대학교 산학협력단 DEPTOR 단백질 억제제 또는 mSIN1 단백질 억제제를 유효성분으로 함유하는 불임 또는 유산의 예방 또는 치료용 약학적 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3882152A (en) * 1970-09-09 1975-05-06 Air Prod & Chem Beta cyclopentadienyl hydrazides and carbazates

Also Published As

Publication number Publication date
MX2019005294A (es) 2019-10-14
US20190330142A1 (en) 2019-10-31
CN109952287A (zh) 2019-06-28
SG11201902465TA (en) 2019-05-30
JP2019535815A (ja) 2019-12-12
EP3535239A1 (en) 2019-09-11
IL266344A (en) 2019-06-30
WO2018085753A1 (en) 2018-05-11
RU2019112671A (ru) 2020-12-07
KR20190114955A (ko) 2019-10-10
AU2017355566A1 (en) 2019-04-04
CA3039070A1 (en) 2018-05-11

Similar Documents

Publication Publication Date Title
CY1123407T1 (el) Σταθερες υδατικες φαρμακοτεχνικες μορφες της αδαλιμουμαμπης
CY1124407T1 (el) Ενωσεις αναστολεα αυτοταξινης
CY1120935T1 (el) Νεες συνθεσεις, χρησεις και μεθοδοι για την παρασκευη αυτων
ECSP17016797A (es) Indazoles sustituidos con benzilo como inhibidores de bub1
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
BR112019002371A2 (pt) composições farmacêuticas
EA201692201A1 (ru) Соединения и композиции в качестве агонистов toll-подобного рецептора 7
MX2016015565A (es) Ciertos inhibidores de la proteina quinasa.
CY1125150T1 (el) Ενωσεις φαινυλο-2-υδροξυ-ακετυλαμινο-2-μεθυλο-φαινυλιου
BR112016012146A2 (pt) Compostos derivados de aminopiridina como inibidores quinase da família tam, composição farmacêutica compreendendo ditos compostos e uso terapêutico dos mesmos
BR112017013568A2 (pt) compostos bicíclicos fundidos para o tratamento de doenças
EA201692143A1 (ru) Производные аминопиразина в качестве ингибиторов фосфатидилинозитол-3-киназы
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
SA519410093B1 (ar) مركبات بيريميدو بيريميدينون مفيدة كمثبطات دبليو إى إى-1 كيناز
CL2019002251A1 (es) Anticuerpos contra triptasa, composiciones de estos y usos de estos.
CY1123574T1 (el) Αντιπολλαπλασιαστικες ενωσεις και φαρμακευτικες συνθεσεις και χρησεις αυτων
EA201790650A1 (ru) Лекарственная форма и способы применения абиратерона ацетата
CL2016003074A1 (es) Compuestos derivados de 2-oxi-2-fenil-n-5-pirrolidin-3-ilamino-1,3,4-tiadiazol-2-ilacetamida, inhibidores gls1 composición farmacéutica y su uso para tratar el cáncer.
CY1124338T1 (el) Αναστολεις 3-φωσφογλυκερικης αφυδρογονασης και χρησεις αυτων
MX2020010116A (es) Compuestos macrociclicos como inhibidores de quinasas del receptor de tropomiosina (trk).
MX2017013875A (es) Ciertos inhibidores de la proteína quinasa.
EA201791992A1 (ru) Ингибиторы грелин-o-ацилтрансферазы
EA201790773A1 (ru) Композиции и способы для ингибирования биологической активности растворимых биомолекул
TR201900659T4 (tr) Mineralokortikoid reseptör modülatörleri olarak benzoksazinon amidleri.
EA201792000A1 (ru) Ингибиторы грелин-o-ацилтрансферазы

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]